Table 3.
Multivariable analyses of HCC recurrence and all-cause mortality according to MAFLD among patients with HBV-related HCC receiving surgical resection after PS-matching or IPTW.
| MAFLD | HCC Recurrence | All-Cause Mortality | |||
|---|---|---|---|---|---|
| Adjusted HR (95% CI) | p-Value | Adjusted HR (95% CI) | p-Value | ||
| PS-Matching | No | 1.00 (reference) | 1.00 (reference) | ||
| Yes | 1.22 (1.05–1.42) | 0.01 | 1.52 (1.21–1.91) | <0.001 | |
| IPTW | No | 1.00 (reference) | 1.00 (reference) | ||
| Yes | 1.26 (1.16–1.36) | <0.001 | 1.44 (1.28–1.61) | <0.001 | |
Abbreviation: HCC, hepatocellular carcinoma; MAFLD, metabolic dysfunction-associated fatty liver disease; HBV, hepatitis B virus; PS, propensity score; IPTW, inverse probability treatment weighting, HR; hazard ratio; CI, confidence interval.